Back
DBV Technologies SA Vs. Akari Therapeutics PLC Industry Stock Comparison
Sell
36
DBVT
DBV Technologies SA
Last Price:
0.62
Seasonality Move:
3.6%
Sell
28
AKTX
Akari Therapeutics PLC
Last Price:
2.30
Seasonality Move:
-8%
Sell
36
DBV Technologies SA (DBVT)
is a Sell
Is DBV Technologies SA a Buy, Sell or Hold?
- The current DBV Technologies SA [DBVT] share price is $0.65. The Score for DBVT is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
- DBVT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
28
Akari Therapeutics PLC (AKTX)
is a Sell
Is Akari Therapeutics PLC a Buy, Sell or Hold?
- The current Akari Therapeutics PLC [AKTX] share price is $2.30. The Score for AKTX is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
- AKTX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
DBVT Stock Price Chart
What is DBV Technologies SA's stock price today?
-
The DBV Technologies SA share price today is $0.65
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DBVT is experiencing slight selling pressure.
AKTX Stock Price Chart
What is Akari Therapeutics PLC's stock price today?
-
The Akari Therapeutics PLC share price today is $2.30
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AKTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
DBVT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.01 | Sell |
| Relative Strength Index (14 RSI): | 37.36 | Sell |
| Chaikin Money Flow: | -21689 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.67 - 0.79) | Sell |
| Bollinger Bands (100): | (0.71 - 0.91) | Sell |
AKTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.13 | Sell |
| Relative Strength Index (14 RSI): | 41.31 | Sell |
| Chaikin Money Flow: | 1958 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.23 - 2.69) | Sell |
| Bollinger Bands (100): | (2.64 - 3.72) | Sell |
DBVT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.73 | Sell |
| 20-day SMA: | 0.74 | Sell |
| 50-day SMA: | 0.74 | Sell |
| 200-day SMA: | 1.13 | Sell |
| 8-day EMA: | 0.71 | Sell |
| 20-day EMA: | 0.73 | Sell |
| 50-day EMA: | 0.76 | Sell |
| 200-day EMA: | 1.16 | Sell |
AKTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.43 | Sell |
| 20-day SMA: | 2.38 | Sell |
| 50-day SMA: | 2.83 | Sell |
| 200-day SMA: | 2.56 | Sell |
| 8-day EMA: | 2.38 | Sell |
| 20-day EMA: | 2.47 | Sell |
| 50-day EMA: | 2.73 | Sell |
| 200-day EMA: | 3.01 | Sell |
DBV Technologies SA Earnings Growth & DBVT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.52 per share, and an increase next year of $0.19 per share.
Akari Therapeutics PLC Earnings Growth & AKTX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.60 per share, and a decrease next year of $0.00 per share.
DBV Technologies SA Technical Analysis
| Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Akari Therapeutics PLC Technical Analysis
| Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||